Adenocarcinoma of the Rectum Clinical Trials

42 clinical trials for Adenocarcinoma of the Rectum across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps — RECRUITING · NA
• A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer — RECRUITING · NA
• A Study of Tucatinib and Trastuzumab in People With Rectal Cancer — RECRUITING · PHASE2
• The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors — RECRUITING
• Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation — RECRUITING
• Concordance of Imaging and Pathology Diagnosis of Extranodal Tumour Deposits — RECRUITING · NA
• A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer — NOT_YET_RECRUITING · PHASE2
• Can we Save the Rectum by Watchful Waiting or TransAnal Surgery Following (Chemo)Radiotherapy Versus Total Mesorectal Excision for Early REctal Cancer? — ACTIVE_NOT_RECRUITING · PHASE2
• Short Course or Long Course Radiotherapy as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer — NOT_YET_RECRUITING · NA
• MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab — COMPLETED · PHASE2
• Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer — TERMINATED · PHASE3
• Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma — COMPLETED · PHASE1
• Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer — COMPLETED · PHASE2
• Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum — COMPLETED · PHASE2
• Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX — TERMINATED · PHASE2
• AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer — TERMINATED · PHASE2
• Human Intestinal Microbiome and Surgical Outcomes in Patients Undergoing Colorectal Cancer Surgery — OTHER
• Midostaurin (PKC412) for Locally Advanced Rectal Cancer — COMPLETED · PHASE1
• Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks — OTHER · PHASE2
• Laparoscopy-Assisted Transanal Endoscopy Rectosigmoid Resection for Rectal Cancer — COMPLETED · NA
• Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer — COMPLETED · PHASE1
• Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer — WITHDRAWN · PHASE2
• Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer — WITHDRAWN · PHASE2
• Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer — COMPLETED · PHASE1
• Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer — COMPLETED · PHASE2
• Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer — COMPLETED · PHASE1
• Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer — COMPLETED · PHASE2
• Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer — COMPLETED · PHASE1
• Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery — COMPLETED · PHASE1
• Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment — COMPLETED · PHASE2
• Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver — COMPLETED · PHASE2
• Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer — COMPLETED · PHASE1
• Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer — COMPLETED · PHASE2
• Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer — TERMINATED · PHASE3
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer — COMPLETED · PHASE1
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer — COMPLETED · PHASE1
• Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer — COMPLETED · PHASE3
• Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated — COMPLETED · PHASE3
• SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer — COMPLETED · PHASE1
• Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer — TERMINATED · PHASE2
• Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum — COMPLETED · PHASE1
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer — COMPLETED · PHASE1

Refine this search